The 7UP product line is the latest food or beverage the Center for Science in the Public Interest (CSPI) has sued under its now-familiar model of private enforcement. The 7UP brand is part of the Dr. Pepper Snapple
Last Thursday, a panel of the Fifth Circuit affirmed a ruling from the Northern District of Texas partially enjoining a Texas company’s sale of ceremonial paddles decorated with the unlicensed insignia of 32 fraternities and sororities. In the lower court,
On Monday, December 3, the United States Court of Appeals for the Second Circuit, in a 2-1 decision, reversed the conviction of a pharmaceutical sales representative for conspiring to introduce a mis-branded drug into interstate commerce solely on the basis
How many different times can you sue your competitor for violating intellectual property rights involving the same product?
At least twice, according to the Court of Appeals for the Federal Circuit (CAFC) in Superior Industries, LLC v. Thor Global Enterprises,
Brand owners look forward to Cyber Monday with high hopes of strong online sales. Cyber Monday can also be extremely lucrative for counterfeiters. This year, however, dozens of counterfeiters received an unwelcome surprise.
The Homeland Security Investigations (HIS) directorate of
On November 19, 2012, the National Advertising Division declared that GreenPan, maker of non-stick cookware, should either change or discontinue advertising its products as “eco-friendly.” See NAD Recommendation.
The National Advertising Division, which is part of the self-regulatory system
The Brand Protection Blog focuses on developments affecting brands and the companies that own them. We believe we would be remiss if we did not report on a significant branding development of our own.
Yesterday, Fulbright & Jaworski (which sponsors
“A company’s or charity’s brand is its most valuable asset.” So said the New York Attorney General (“NYAG”) on October 18, in a guidance document (“the Guidance”) relating to companies that support charities by promising donations from the sale of
On October 5, 2012, the FDA issued warning letters to two beauty and personal products companies—including multinational giant Avon Products—objecting to promotional claims that the companies make in connection with their “cosmeceutical” products. In both cases, the